HOME   |    PDF   |   


Title

Effects of intravenous lignocaine, dexamethasone and their combination on propofol-induced pain

 

Authors

Pragyashri Baghel1, Ikraz Patel2, Anushree Shukla3 & Gopal Eekwale4,*

 

Affiliation

1Department of Anaesthesia, NSCB Medical College, Jabalpur, Madhya Pradesh, India; 2Department of Medicine, SAIMS Medical College, Indore, Madhya Pradesh, India; 3Department of Anesthesia, Apollo Hospitals, Indore, Madhya Pradesh, India; 4Department of Anaesthesiology, M.G.M. Medical College & MY Hospital, Indore, Madhya Pradesh, India; *Corresponding author

 

Email

Pragyashri Baghel - E-mail: pragyashri.baghel@gmail.com

Ikraz Patel - E-mail: ikrazpatel4444@gmail.com

Anushree Shukla - E-mail: shukla.anu1993@gmail.com

Gopal Eekwale - E-mail: gopal.ekwale@gmail.com

 

Article Type

Research Article

 

Date

Received August 1, 2025; Revised August 31, 2025; Accepted August 31, 2025, Published August 31, 2025

 

Abstract

Injection of propofol may provoke pain in up to 70 percent of the patients. In this randomized, double-blind study, the effects of lignocaine, dexamethasone and a combination of both on propofol-induced pain were evaluated in 90 surgical patients. The highest incidence of pain found was in the lignocaine group (70%) and the lowest in the combination group (30%). The combined pretreatment also showed significantly reduced mean pain scores (p < 0.01). The combination of lignocaine-dexamethasone was best effective and this might be embraced in reducing propofol-induced pain.

 

Keywords

Propofol-induced pain, lignocaine, dexamethasone, intravenous anesthesia, pain management, pre-treatment agents

 

Citation

Baghel et al. Bioinformation 21(8): 2603-2607 (2025)

 

Edited by

Vini Mehta

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.